Linked Life Data

17679566

Source:http://linkedlifedata.com/resource/pubmed/id/17679566

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2007-8-7
pubmed:abstractText
Ondansetron is currently being explored as a treatment for motion sickness due to its proven prophylactic effect on post-operative nausea, the nausea and vomiting associated with chemotherapy, and its lack of side effects. This study sought to compare the effectiveness of placebo, dimenhydrinate, and ondansetron for preventing motion sickness in highly susceptible subjects.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0095-6562
pubmed:author
pubmed:issnType
Print
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
686-92
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
High dose ondansetron for reducing motion sickness in highly susceptible subjects.
pubmed:affiliation
Department of Psychology, Clemson University, Clemson, SC 29634, USA. muth@clemson.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't